CAD 0.43
(6.25%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -498.94 Thousand CAD | -455.61% |
2022 | 100.62 Thousand USD | 1895.78% |
2021 | 5042.00 CAD | 110.6% |
2020 | -47.57 Thousand CAD | 8.23% |
2019 | -51.83 Thousand CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 47.43 Thousand USD | 83.64% |
2024 Q2 | 171.72 Thousand USD | 262.05% |
2023 Q2 | 85.17 Thousand USD | 25.34% |
2023 Q1 | 67.95 Thousand USD | 23.35% |
2023 FY | -357.83 Thousand CAD | -455.61% |
2023 Q4 | 25.82 Thousand USD | -5.93% |
2023 Q3 | 27.45 Thousand USD | -67.77% |
2022 Q3 | 45.52 Thousand CAD | 171.72% |
2022 Q1 | -213.12 Thousand CAD | -428.44% |
2022 Q2 | 16.75 Thousand CAD | 107.86% |
2022 FY | 100.62 Thousand USD | 1895.78% |
2022 Q4 | 55.09 Thousand USD | 21.02% |
2021 Q1 | -11.82 Thousand CAD | 0.0% |
2021 Q2 | -18.29 Thousand CAD | -54.66% |
2021 Q3 | -18.34 Thousand CAD | -0.26% |
2021 Q4 | -40.33 Thousand CAD | -119.9% |
2021 FY | 5042.00 CAD | 110.6% |
2020 Q1 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 FY | -47.57 Thousand CAD | 8.23% |
2019 Q1 | - CAD | 0.0% |
2019 FY | -51.83 Thousand CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Therma Bright Inc. | 23.89 Thousand CAD | 2187.732% |
Theralase Technologies Inc. | 562.13 Thousand CAD | 188.759% |
VentriPoint Diagnostics Ltd. | 42.43 Thousand CAD | 1275.819% |